Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664
What this trial is testing

Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00520845
What this trial is testing

Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 23
Early research (Phase 1)Ended earlyNCT02991651
What this trial is testing

Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Io Therapeutics 12
Large-scale testing (Phase 3)Looking for participantsNCT03851445
What this trial is testing

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Who this might be right for
Previously Treated Non-Small Cell Lung Cancer
SWOG Cancer Research Network 10,000
Testing effectiveness (Phase 2)Study completedNCT02730247
What this trial is testing

Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Liza Villaruz, MD 7
Testing effectiveness (Phase 2)WithdrawnNCT00268255
What this trial is testing

Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT00066768
What this trial is testing

Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Ended earlyNCT01244191
What this trial is testing

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Who this might be right for
Non Squamous, Non-small-cell Lung Cancer
Daiichi Sankyo 1,048
Testing effectiveness (Phase 2)Study completedNCT00548093
What this trial is testing

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Who this might be right for
Carcinoma, Non Small Cell Lung
Pfizer 66
Testing effectiveness (Phase 2)Study completedNCT01438307
What this trial is testing

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Stage IV NSCLCMetastatic NSCLC
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Study completedNCT01945021
What this trial is testing

Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

Who this might be right for
Non Small Cell Lung CancerROS1 Proto OncogeneCrizotinib
Pfizer 129
Testing effectiveness (Phase 2)Study completedNCT01138163
What this trial is testing

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Peregrine Pharmaceuticals 121
Testing effectiveness (Phase 2)Ended earlyNCT02967133
What this trial is testing

Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer MetastaticNon-Small Cell Carcinoma of Lung, TNM Stage 4Nonsmall Cell Lung Cancer+1 more
Alliance Foundation Trials, LLC. 7
Testing effectiveness (Phase 2)Study completedNCT01676714
What this trial is testing

Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer

Who this might be right for
Non-Small Cell Lung CancerColorectal Cancer
University of California, Davis 10
Testing effectiveness (Phase 2)UnknownNCT00022243
What this trial is testing

T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Lung Cancer
Tularik
Large-scale testing (Phase 3)Looking for participantsNCT06735391
What this trial is testing

A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations

Who this might be right for
Locally Advanced or Metastatic Non-squamous NSCLCHarboring EGFR Sensitive Mutations NSCLCPreviously Untreated Systematically NSCLC
Shanghai JMT-Bio Inc. 516
Testing effectiveness (Phase 2)Ended earlyNCT02087176
What this trial is testing

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

Who this might be right for
Previously Treated Non Small Cell Lung Cancer
AstraZeneca 48
Early research (Phase 1)Study completedNCT00434174
What this trial is testing

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT03096782
What this trial is testing

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia+19 more
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT07154368
What this trial is testing

JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.

Who this might be right for
Non Small Cell Lung Cancer
Guangzhou JOYO Pharma Co., Ltd 207
Next Page